Home Cart 0 Sign in  

[ CAS No. 79069-15-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 79069-15-1
Chemical Structure| 79069-15-1
Structure of 79069-15-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 79069-15-1 ]

Related Doc. of [ 79069-15-1 ]

Alternatived Products of [ 79069-15-1 ]

Product Details of [ 79069-15-1 ]

CAS No. :79069-15-1 MDL No. :MFCD00235945
Formula : C15H23NO4 Boiling Point : -
Linear Structure Formula :- InChI Key :MSIDLARYVJJEQY-ZDUSSCGKSA-N
M.W : 281.35 Pubchem ID :14427183
Synonyms :

Calculated chemistry of [ 79069-15-1 ]

Physicochemical Properties

Num. heavy atoms : 20
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.53
Num. rotatable bonds : 9
Num. H-bond acceptors : 4.0
Num. H-bond donors : 2.0
Molar Refractivity : 76.62
TPSA : 67.79 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.84 cm/s

Lipophilicity

Log Po/w (iLOGP) : 3.03
Log Po/w (XLOGP3) : 1.66
Log Po/w (WLOGP) : 1.94
Log Po/w (MLOGP) : 1.49
Log Po/w (SILICOS-IT) : 2.03
Consensus Log Po/w : 2.03

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.26
Solubility : 1.55 mg/ml ; 0.00552 mol/l
Class : Soluble
Log S (Ali) : -2.7
Solubility : 0.565 mg/ml ; 0.00201 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.77
Solubility : 0.0473 mg/ml ; 0.000168 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 3.19

Safety of [ 79069-15-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 79069-15-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 79069-15-1 ]
  • Downstream synthetic route of [ 79069-15-1 ]

[ 79069-15-1 ] Synthesis Path-Upstream   1~21

  • 1
  • [ 23680-31-1 ]
  • [ 79069-15-1 ]
Reference: [1] Journal of the American Chemical Society, 2017, vol. 139, # 19, p. 6726 - 6735
[2] Tetrahedron Letters, 1995, vol. 36, # 8, p. 1223 - 1226
[3] Journal of Organic Chemistry, 1981, vol. 46, # 23, p. 4799 - 4800
[4] Bioorganic and Medicinal Chemistry Letters, 1997, vol. 7, # 9, p. 1119 - 1122
[5] Journal of Organic Chemistry, 1981, vol. 46, # 23, p. 4797 - 4798
[6] Tetrahedron Letters, 1993, vol. 34, # 41, p. 6513 - 6516
[7] Journal of Organic Chemistry, 1996, vol. 61, # 20, p. 6994 - 6996
[8] Bioorganic and Medicinal Chemistry Letters, 1996, vol. 6, # 15, p. 1799 - 1804
[9] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 6, p. 1486 - 1490
[10] Synthetic Communications, 1996, vol. 26, # 13, p. 2511 - 2522
[11] Synthesis, 1990, p. 299 - 301
[12] Patent: WO2011/69149, 2011, A2, . Location in patent: Page/Page column 26
[13] Bioorganic and Medicinal Chemistry, 2012, vol. 20, # 2, p. 702 - 713
[14] Tetrahedron Letters, 2012, vol. 53, # 26, p. 3225 - 3229
[15] Tetrahedron Letters, 2012, vol. 53, # 32, p. 4216 - 4220
[16] Synlett, 2013, vol. 24, # 6, p. 747 - 751
  • 2
  • [ 66866-45-3 ]
  • [ 79069-15-1 ]
YieldReaction ConditionsOperation in experiment
8.47 g With sodium tetrahydroborate In water at 0℃; for 0.5 h; To a stirred solution of 28 (9.28 g, 31.7 mmol) and N-methyl morpholine (3.7 mL, 33.7 mmol) in DME (70 mL) was added isobutyl chloroformate (4.3 mL, 33.3 mmol) at -20 °C under argon atmosphere. After being stirred for 30 min at 0 °C, the reaction mixture was filtered to remove the resulting precipitates. To a cooled suspension of sodium borohydride (2.5 g, 66.5 mmol) in water (30 mL) was added the filtrate at 0 °C. Stirring was continued for additional 30 min at the same temperature. The reaction mixture was diluted with EtOAc, washed with hydrochloric acid, water, brine, and dried over Na2SO4. The organic layer was removed by evaporation to give an alcohol 29 as a colorless oil (8.47 g, 96percent). 1H NMR (300 MHz, CDCl3): δ 1.43 (s, 9H), 3.60-3.83 (m, 6H), 4.54 (s, 2H), 5.17 (br s, 1H), 7.40-7.28 (m, 5H).
Reference: [1] Synthetic Communications, 1996, vol. 26, # 13, p. 2511 - 2522
[2] Nucleosides and Nucleotides, 1999, vol. 18, # 8, p. 1845 - 1861
[3] Bioorganic and Medicinal Chemistry, 2012, vol. 20, # 2, p. 702 - 713
  • 3
  • [ 13650-73-2 ]
  • [ 79069-15-1 ]
Reference: [1] Patent: EP1481976, 2004, A1, . Location in patent: Page 226
  • 4
  • [ 23680-31-1 ]
  • [ 541-41-3 ]
  • [ 79069-15-1 ]
Reference: [1] Patent: EP1679296, 2006, A1, . Location in patent: Page/Page column 29
  • 5
  • [ 24424-99-5 ]
  • [ 10433-52-0 ]
  • [ 79069-15-1 ]
Reference: [1] Patent: US2012/28995, 2012, A1, . Location in patent: Page/Page column 70
  • 6
  • [ 79069-54-8 ]
  • [ 79069-15-1 ]
Reference: [1] Tetrahedron Letters, 2005, vol. 46, # 17, p. 2965 - 2968
  • 7
  • [ 65559-43-5 ]
  • [ 79069-15-1 ]
Reference: [1] Tetrahedron Letters, 2007, vol. 48, # 47, p. 8323 - 8325
  • 8
  • [ 80963-10-6 ]
  • [ 79069-15-1 ]
Reference: [1] Synthesis, 1997, # 10, p. 1146 - 1150
[2] Tetrahedron Letters, 2000, vol. 41, # 49, p. 9499 - 9503
[3] Tetrahedron Letters, 2012, vol. 53, # 26, p. 3225 - 3229
  • 9
  • [ 23680-31-1 ]
  • [ 543-27-1 ]
  • [ 79069-15-1 ]
YieldReaction ConditionsOperation in experiment
82% With sodium tetrahydroborate; triethanolamine In tetrahydrofuran; water; ethyl acetate N-(tert-Butyloxycarbonyl)-O-Benzyl-L-Serinol (3)
N-(tert-butyloxycarbonyl)-O- benzyl-L-serine 2 (6.0 g, 20.34 mmol) was dissolved in dry THF and cooled to -20° C. under argon atmosphere.
To this cold stirred solution was added TEA (2.32 g, 23 mmol) and isobutyl chloroformate (3.13 g, 23 mmol).
The stirring was continued for 30 min at -20° C. under argon atmosphere.
The reaction mixture was filtered immediately under a blanket of argon, the precipitate was washed with dry THF (50 ml).
The combined filtrate was added slowly into a cold (0° C.) solution of NaBH4 (7.4 g, 200 mmol) in THF/water (80:20, 200 ml) during 10 min period.
After the addition, the reaction mixture was stirred for 2 h at 0° C. and the pH adjusted to 7 with acetic acid.
The solution was evaporated to dryness, partitioned between ethyl acetate/water (300:150 ml) and extracted in ethyl acetate.
The organic extract was washed with brine (100 ml), dried over anhydrous sodium sulfate and evaporated to dryness.
The crude product was purified by flash column chromatography over silica gel using CH2 Cl2 -->EtOAc as the eluent.
The pure product was pooled together and evaporated to dryness to give 4.7 g (82percent) of the pure product as an oil. 1 H-NMR (CDCl3): δ1.41 (s, 9H, Boc), 3.60-3.70 (m, 4H), 3.82 (d, 2H), 4.53 (s, 2H, OCH2 Ph), 5.20 (bs, 1H, NH) and 7.30-7.40 (m, 5H, Ph).
Reference: [1] Patent: US5969135, 1999, A,
  • 10
  • [ 24424-99-5 ]
  • [ 79069-15-1 ]
Reference: [1] Bioorganic and medicinal chemistry letters, 2004, vol. 14, # 1, p. 275 - 278
[2] Synthesis, 1997, # 10, p. 1146 - 1150
[3] Bioorganic and Medicinal Chemistry Letters, 1996, vol. 6, # 15, p. 1799 - 1804
[4] Tetrahedron Letters, 2012, vol. 53, # 26, p. 3225 - 3229
  • 11
  • [ 4726-96-9 ]
  • [ 79069-15-1 ]
Reference: [1] Bioorganic and medicinal chemistry letters, 2004, vol. 14, # 1, p. 275 - 278
[2] Nucleosides and Nucleotides, 1999, vol. 18, # 8, p. 1845 - 1861
[3] Synthesis, 1997, # 10, p. 1146 - 1150
[4] Bioorganic and Medicinal Chemistry Letters, 1996, vol. 6, # 15, p. 1799 - 1804
  • 12
  • [ 142285-65-2 ]
  • [ 79069-15-1 ]
Reference: [1] Tetrahedron Letters, 2005, vol. 46, # 17, p. 2965 - 2968
  • 13
  • [ 226931-87-9 ]
  • [ 79069-15-1 ]
Reference: [1] Tetrahedron Letters, 2005, vol. 46, # 17, p. 2965 - 2968
  • 14
  • [ 505084-92-4 ]
  • [ 79069-15-1 ]
Reference: [1] Tetrahedron Letters, 2005, vol. 46, # 17, p. 2965 - 2968
  • 15
  • [ 95715-85-8 ]
  • [ 79069-15-1 ]
Reference: [1] Organic Letters, 2004, vol. 6, # 1, p. 15 - 18
  • 16
  • [ 126181-46-2 ]
  • [ 79069-15-1 ]
Reference: [1] Organic Letters, 2004, vol. 6, # 1, p. 15 - 18
  • 17
  • [ 1072841-05-4 ]
  • [ 79069-15-1 ]
Reference: [1] Journal of Chemical Research, 2007, # 12, p. 683 - 685
  • 18
  • [ 505085-04-1 ]
  • [ 79069-15-1 ]
Reference: [1] Tetrahedron Letters, 2005, vol. 46, # 17, p. 2965 - 2968
  • 19
  • [ 19525-87-2 ]
  • [ 79069-15-1 ]
Reference: [1] Synthesis, 1997, # 10, p. 1146 - 1150
  • 20
  • [ 3262-72-4 ]
  • [ 79069-15-1 ]
Reference: [1] Patent: WO2011/69149, 2011, A2,
[2] Tetrahedron Letters, 2012, vol. 53, # 26, p. 3225 - 3229
  • 21
  • [ 100-39-0 ]
  • [ 79069-15-1 ]
Reference: [1] Patent: WO2011/69149, 2011, A2,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 79069-15-1 ]

Amino Acid Derivatives

Chemical Structure| 66674-16-6

[ 66674-16-6 ]

(S)-Benzyl (1-hydroxypropan-2-yl)carbamate

Similarity: 0.89

Chemical Structure| 1676-75-1

[ 1676-75-1 ]

(S)-2-(((Benzyloxy)carbonyl)amino)-3-(tert-butoxy)propanoic acid

Similarity: 0.87

Chemical Structure| 23680-31-1

[ 23680-31-1 ]

Boc-Ser(Bzl)-OH

Similarity: 0.87

Chemical Structure| 65806-90-8

[ 65806-90-8 ]

Z-D-Ser(TBu)-OH

Similarity: 0.87

Chemical Structure| 47173-80-8

[ 47173-80-8 ]

Boc-D-Ser(Bzl)-OH

Similarity: 0.87